I
I

Price • INmune Bio

INMB

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.

Historical stock price chart and annual return over the past years

137%

5 years

% Total

INMB
19%

5 years

Annual Return

INMB